Entresto and valsartan are both medications used to treat heart failure, but they work differently and are prescribed for distinct situations.
What is Entresto and How Does It Work?
Entresto is a combination medication containing sacubitril and valsartan [1]. Sacubitril is a neprilysin inhibitor, while valsartan is an angiotensin II receptor blocker (ARB) [1]. This dual action helps to reduce the workload on the heart and improve its pumping function [1]. It is prescribed for patients with chronic heart failure with reduced ejection fraction (HFrEF) to lower the risk of cardiovascular death and hospitalization [1].
What is Valsartan and What Is It Used For?
Valsartan is an ARB that specifically blocks the action of angiotensin II, a hormone that narrows blood vessels [2]. By preventing this narrowing, valsartan helps to lower blood pressure and reduce the strain on the heart [2]. It is used to treat high blood pressure, heart failure, and to improve survival after a heart attack [2].
How is Entresto Different from Valsartan Alone?
The key difference lies in their composition and mechanism of action. Valsartan, as a standalone drug, only acts as an ARB. Entresto combines valsartan with sacubitril, which adds the benefit of neprilysin inhibition [1]. This combined approach in Entresto has been shown to be more effective than an ACE inhibitor or ARB alone in reducing cardiovascular mortality and heart failure hospitalizations in certain patient populations [1].
When is Entresto Prescribed Instead of Valsartan?
Entresto is typically prescribed for patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF) who remain symptomatic despite treatment with an ACE inhibitor or ARB, or who cannot tolerate them [1]. It is a later-line therapy or an alternative for those whose condition is not adequately managed by ARBs or ACE inhibitors alone [1].
What Are the Potential Side Effects of Each Drug?
Both Entresto and valsartan can cause similar side effects due to the valsartan component, such as low blood pressure, dizziness, and kidney problems [1][2]. Additionally, Entresto can increase the risk of angioedema (swelling of the face, lips, tongue, or throat), particularly in patients with a history of this condition [1].
How Long Until Entresto or Valsartan Start Working?
The therapeutic effects of both medications develop over time. Patients may begin to notice improvements in symptoms like shortness of breath and fatigue within weeks of starting treatment, but significant benefits, such as reduced hospitalization or mortality, are observed over longer periods of consistent use [1][2].
Are There Alternatives to Entresto and Valsartan for Heart Failure?
Yes, other drug classes are used to manage heart failure, including ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists (MRAs), and newer medications like SGLT2 inhibitors [3]. The choice of medication depends on the specific type of heart failure, the patient's symptoms, and their overall health status [3].
What is the Patent Status for Entresto?
Information regarding the patent status of Entresto can be found on specialized pharmaceutical patent databases [4]. Patents for drugs like Entresto are crucial for determining market exclusivity and the potential for generic competition [4].